Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression
€
2.42
Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression quantity
Add to cart
SKU:
product-article-18799
Category:
General
Description
Description
Adding elotuzumab to standard treatment for multiple myeloma delays disease progression
Related products
Article: Highlights in respiratory oncology
€
2.42
Add to cart
Article: Highlights in urologic cancer
€
2.42
Add to cart
Article: Highlights in breast cancer
€
2.42
Add to cart
Article: Highlights in gynaecological cancers
€
2.42
Add to cart